Lunai Bioworks Inc. Common Stock (RENB)

• Market cap: $40M
• 1 day: -9.12%
• 5 days: -20.32%
• 1 month: -25.08%
• 3 months: -49.88%
• 6 months: -77.43%
• Year to date: -77.29%
• 1 year: -72.83%
• 5 years: -95.33%
• 10 years: -97.94%
• Sector: Healthcare
• Industry: Biotechnology

About: Lunai Bioworks Inc is a biopharmaceutical company. It is engaged in developing new immunotherapies to combat cancer and developing a predicative artificial intelligence-based diagnostic methodology for the use of earlier cancer detection.

Employees: 25

Fund manager confidence

Based on 2025 Q2 regulatory disclosures by fund managers ($100M+ AUM)

5.17% less ownership

Funds ownership: 13.56% [Q1] → 8.38% (-5.17%) [Q2]

29% less funds holding

Funds holding: 63 [Q1] → 45 (-18) [Q2]

56% less first-time investments, than exits

New positions opened: 14 | Existing positions closed: 32

58% less repeat investments, than reductions

Existing positions increased: 8 | Existing positions reduced: 19

65% less capital invested

Capital invested by funds: $12M [Q1] → $4.17M (-$7.79M) [Q2]